Presentation TCT 2012

The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.

Presenter: David R. Rutledge, James B. Hermiller, Jin Wang, Mitchell W. Krucoff

January 03, 2012

REGISTER for free or LOG IN to view this content

The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.

DES/BRS/DCB

Presentation

TCT 2012

Up Next

Presentation TCT 2012

Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents

Presenter: Hao Xu

January 03, 2012

More slides +

Presentation TCT 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presenter: Klaus Bonaventura

January 03, 2012

Presentation TCT 2012

Prior Coronary Artery Bypass Graft (CABG) Patients Treated with Primary Percutaneous Coronary Intervention (PPCI) Have Higher Long-Term Major Adverse Cardiovascular Event...

Presenter: Mohammed M. Akhtar

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.